Hugo joined MVM in 2005. Before joining MVM, he qualified as a chartered accountant with KPMG. Hugo has a degree in Molecular and Cellular Biochemistry from Oxford University.
Hugo is a member of the boards of SkyCell AG, Gynesonics, Inc, Vertos Medical, Inc and Nalu Medical, Inc.
He was previously a director of Horizon Discovery Limited (LSE: HZD, acquired by PerkinElmer), Accuvein, Inc., and eZono AG, and led MVM’s investment into BioVex Limited (acquired by Amgen).
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |